Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The AAPS Journal|September 2, 2023
Anti-drug Antibody Magnitude and Clinical Relevance Using Signal to Noise (S/N): Bococizumab Case StudyFred McCush, Ellen Wang, Carla Yunis, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 25, 2010
Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeuticsDeborah Finco, Daniel Baltrukonis, Adrienne Clements-Egan, et al.
The AAPS Journal|December 18, 2013
Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamSherri Dudal, Daniel Baltrukonis, Rebecca Crisino, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 19, 2019
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal AntibodiesEllen Q Wang, Jack F Bukowski, Carla Yunis, et al.
British Journal of Clinical Pharmacology|May 6, 2015
Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human studyJennifer Q Dong, Michelle Rossulek, Veena R Somayaji, et al.
The AAPS Journal|June 20, 2019
Anti-drug Antibody Assay Validation: Improved Reporting of the Assay Selectivity via Simpler Positive Control Recovery Data AnalysisBoris Gorovits, Marcela Araya Roldan, Daniel Baltrukonis, et al.
Journal of Applied Toxicology : JAT|June 25, 2019
Lens cholesterol biosynthesis inhibition: A common mechanism of cataract formation in laboratory animals by pharmaceutical productsMichael D Aleo, Colleen M Doshna, Daniel Baltrukonis, et al.
Pageof 2